| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |